Effect of ketoconazole and rifampin on the single dose pharmacokinetics of asoprisnil and its metabolite in healthy female subjects.

被引:0
|
作者
Lee, RD [1 ]
Witt, G [1 ]
Chwalisz, K [1 ]
机构
[1] TAP Pharmaceut Prod Inc, Lake Forest, IL USA
关键词
D O I
10.1016/j.clpt.2005.12.176
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P49 / P49
页数:1
相关论文
共 50 条
  • [41] PHARMACOKINETICS AND PHARMACODYNAMICS OF A SINGLE INTRAVENOUS DOSE OF HM10760A IN HEALTHY KOREAN SUBJECTS.
    Kim, S.
    Lee, S.
    Yoon, S.
    Lim, K. S.
    Shin, S. G.
    Yu, K. S.
    Jang, I. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S81 - S82
  • [42] Single-dose pharmacokinetics of the direct renin inhibitor aliskiren in healthy Chinese subjects.
    Bartlett, M.
    Vaidyanathan, S.
    Karan, R. S.
    Hu, P.
    Howard, D.
    Yeh, C. M.
    Dieterich, H. A.
    Al-Fayoumi, S.
    Jarugula, V.
    Doles, W. P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S62 - S62
  • [43] Single- and multiple-dose pharmacokinetics of SDZ HTF 919 in healthy subjects.
    Appel-Dingemanse, S
    Guerret, M
    Hirschberg, Y
    McLeod, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 128 - 128
  • [44] EFFECT OF SINGLE- DOSE RIFAMPIN ON THE PHARMACOKINETICS OF WARFARIN IN HEALTHY VOLUNTEERS.
    Frymoyer, A.
    Shugarts, S.
    Browne, M.
    Wu, A. H.
    Frassetto, L.
    Benet, L. Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S4 - S4
  • [45] Single dose pharmacokinetics of faropenem daloxate in adolescent subjects.
    van den Anker, J
    Rajagopalan, P
    Rakhmanina, N
    Murty, V
    Sundaresan, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P93 - P93
  • [46] Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone in healthy subjects.
    Lebrun-Vignes, B
    Chosidow, O
    Diquet, B
    Levron, JC
    Herson, S
    Corbrion-Archer, V
    Puech, AJ
    Warot, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 683 - 683
  • [47] Lack of effect of aprepitant on digoxin pharmacokinetics in healthy subjects.
    Lee, Y
    Orlowski, LH
    Michiels, N
    Petty, KJ
    Goldberg, MR
    Dru, J
    Chavez-Eng, CM
    Constanzer, M
    Murphy, G
    Gottesdiener, K
    Hesney, M
    Feuring, M
    Wehling, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P66 - P66
  • [48] EFFECT OF ACTIVATED CHARCOAL ON THE PHARMACOKINETICS OF APIXABAN IN HEALTHY SUBJECTS.
    Wang, X.
    Tirucherai, G.
    Pannacciulli, N.
    Wang, J.
    Elsrougy, A.
    Teslenko, V.
    Chang, M.
    Zhang, D.
    Frost, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S41 - S41
  • [49] Effects of Single Dose Rifampin on the Pharmacokinetics of Fluvastatin in Healthy Volunteers
    Xiang, Yue
    Okochi, Hideaki
    Kozachenko, Ivan
    Sodhi, Jasleen K.
    Frassetto, Lynda A.
    Benet, Leslie Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (02) : 480 - 485
  • [50] Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects
    Farid, N. A.
    Jakubowski, J. A.
    Payne, C. D.
    Li, Y. G.
    Jin, Y.
    Ernest, C. S., II
    Winters, K. J.
    Brandt, J. T.
    Salazar, D. E.
    Small, D. S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (08) : 1821 - 1829